ArticleFrontiers in immunology2024

Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19.

Ziping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.